Cinacalcet Tablets recalled over manufacturing violations
- Recall date
- November 27, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- AvKARE recalls Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-460-30
- Recall number
- D-0109-2025
- FDA classification
- Class II
- Brand / firm
- AvKARE
- Sold / distributed
- USA Nationwide
Why it was recalled
CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-460-30
Get recall alerts
Free email alert whenever AvKARE has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: AvKARE